AVEG 020

A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID) October 22, 1997
gp120 C4-V3 Env gp120 C4-V3 B
gp120 C4-V3 Protein
USA 24